NCT06336070 (POWER Health) is a NA clinical trial of HIIT program (8 weeks) in Breast Cancer Female, sponsored by University of Valencia.

Who is sponsoring NCT06336070?

NCT06336070 is sponsored by University of Valencia.

What drugs are being tested in NCT06336070?

Interventions in NCT06336070: HIIT program (8 weeks), MPI program (8 weeks).

What condition does NCT06336070 study?

NCT06336070 studies Breast Cancer Female, Cardiometabolic Syndrome, Metabolism Disorder, Lipid, Autonomic Dysfunction, Cardiovascular Diseases in Old Age.

Is NCT06336070 still recruiting?

NCT06336070 is currently recruiting now. Last updated 4 April 2024.

Last reviewed 2024-04-04 · How we verify

NCT06336070: POWER Health

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Metabolic Flexibility and Autonomic Control After Muscle Power vs Metabolic Power Training in Postmenopausal Oncological Women: the POWER Health Study

Recruiting now NA Last updated 4 April 2024

What this trial tests

NA trial testing HIIT program (8 weeks) in Breast Cancer Female in 56 participants. Currently enrolling.

Timeline

1 January 2024

Primary endpoint
31 December 2027

31 December 2028

Quick facts

Lead sponsor	University of Valencia
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	56
Start date	1 January 2024
Primary completion	31 December 2027
Estimated completion	31 December 2028
Sites	1 location across Spain

Drugs / interventions tested

HIIT program (8 weeks)
MPI program (8 weeks)

Conditions studied

Breast Cancer Female — all drugs for Breast Cancer Female →
Cardiometabolic Syndrome — all drugs for Cardiometabolic Syndrome →
Metabolism Disorder, Lipid — all drugs for Metabolism Disorder, Lipid →
Autonomic Dysfunction — all drugs for Autonomic Dysfunction →

Sponsor

University of Valencia

Who can join

Adults 35 to 75, female only, with Breast Cancer Female or Cardiometabolic Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

POWER Health is a randomized clinical trial with a two-arm parallel design whose objectives are 1) to study metabolic flexibility and autonomic function (both capacities that describe cardiovascular health) in a sample of postmenopausal oncological women vs postmenopausal untreated controls (CT); and 2) to analyze the impact of two different 8-week physical exercise supervised interventions: HIIT training vs strength training focused on muscle power, on both cardiovascular capacities in these populations.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Vagal Activity and Fat Oxidation Basal Correlates in Older Active Postmenopausal Women: A Cross-Sectional Study.
Monferrer-Marín J, Roldán A, Helge JW, Blasco-Lafarga C. · · 2026 · PMID 41820730 · DOI 10.1186/s40798-026-01004-1
Vagal activity and fat oxidation correlates during basal metabolic rate in active postmenopausal women
Monferrer-Marín J, Roldán A, Helge JW, Blasco-Lafarga C. · · 2025 · DOI 10.21203/rs.3.rs-7443225/v1

Verify or expand the search:

Other recruiting trials for Breast Cancer Female

Currently open trials in the same condition.

NCT07505797 — ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) · recruiting
NCT07198724 — ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrin · Phase 1, PHASE2 · recruiting
NCT07331506 — Validation of the Oncoliq Test for the Early Detection of Breast Cancer. · recruiting
NCT07214883 — UCF MammoChat: Image Repository · recruiting
NCT07120100 — Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Surviv · NA · recruiting

Other University of Valencia trials

Trials by the same sponsor.

NCT07509281 — Peri-implant Tissues Changes for Different Abutment Shapes and Heights · NA · not yet recruiting
NCT07535528 — Implant Placement Depth and Peri-Implant Tissue Outcomes · NA · not yet recruiting
NCT07471555 — Vascular Access and Intraosseus · NA · enrolling by invitation
NCT07463066 — Long-Term Effectiveness of Pain Neuroscience Education in Women With Genito-Pelvic Pain/Penetration Disorder. · not yet recruiting
NCT07419399 — Acute Effects of Radiofrequency Diathermy in Postpartum Women With Diastasis Abdominis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06336070 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Valencia
Last refreshed: 4 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06336070.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing